Sung Kook Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sung Kook Kim has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Eun Young Kim
Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, South Korea
3 shared publicationsKyeong Ok Kim
Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, South Korea
3 shared publicationsYoo Jin Lee
Department of Internal Medicine, Keimyung University School of Medicine, Daegu, South Korea
3 shared publicationsByung Ik Jang
Yeungnam University
2 shared publicationsHyeong Ho Jo
Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, South Korea
2 shared publicationsHyun Seok Lee
Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea
2 shared publications
Latest Publications
- Open Access
- 24 April 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-9
Mobile monitoring system detects the disease activity pattern and shows the association with clinical outcomes in patients with newly diagnosed Crohn’s disease
We aimed to determine whether Crohn’s disease (CD) activity patterns assessed via a web-based symptom diary can help predict clinical outcomes in patients with newly diagnosed CD. Patients diagnosed with CD within the preceding 3 months were prospectively enrolled at four tertiary centers. All patients recorded their symptoms on a website using a smartphone at least once a week. The index outcomes were disease-related admission and surgery during follow-up. The disease activity from enrollment to outcome or last follow-up was reviewed for pattern analysis. Cox regression analysis was used to identify the predictors of disease outcomes. A total of 102 patients were enrolled. During a median follow-up period of 42 months, 25 (24.5%) and 6 (5.9%) patients required admission and surgery, respectively. Poor activity pattern was an independent predictor of disease-related hospitalization (adjusted hazard ratio [aHR], 3.96; 95% confidence interval [CI] 1.5–10.45; p = 0.005). A poor activity pattern (aHR, 19.48; 95% CI 1.86–203.95; p = 0.013) and female sex (aHR, 11.28; 95% CI 1.49–85.01; p = 0.018) were found to be independent predictors of bowel resection. CD disease activity patterns monitored through the mobile monitoring system may help predict clinical outcomes, such as disease-related hospitalization and surgery, in patients with newly diagnosed CD.
- 24 April 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-9
Open AccessMobile monitoring system detects the disease activity pattern and shows the association with clinical outcomes in patients with newly diagnosed Crohn’s disease
We aimed to determine whether Crohn’s disease (CD) activity patterns assessed via a web-based symptom diary can help predict clinical outcomes in patients with newly diagnosed CD. Patients diagnosed with CD within the preceding 3 months were prospectively enrolled at four tertiary centers. All patients recorded their symptoms on a website using a smartphone at least once a week. The index outcomes were disease-related admission and surgery during follow-up. The disease activity from enrollment to outcome or last follow-up was reviewed for pattern analysis. Cox regression analysis was used to identify the predictors of disease outcomes. A total of 102 patients were enrolled. During a median follow-up period of 42 months, 25 (24.5%) and 6 (5.9%) patients required admission and surgery, respectively. Poor activity pattern was an independent predictor of disease-related hospitalization (adjusted hazard ratio [aHR], 3.96; 95% confidence interval [CI] 1.5–10.45; p = 0.005). A poor activity pattern (aHR, 19.48; 95% CI 1.86–203.95; p = 0.013) and female sex (aHR, 11.28; 95% CI 1.49–85.01; p = 0.018) were found to be independent predictors of bowel resection. CD disease activity patterns monitored through the mobile monitoring system may help predict clinical outcomes, such as disease-related hospitalization and surgery, in patients with newly diagnosed CD.
- Open Access
- 18 August 2023
- Published by Springer Nature in Research Square
Mobile monitoring system to detect the disease activity pattern and predict clinical outcomes in patients with newly diagnosed Crohn’s disease
We aimed to determine whether Crohn’s disease (CD) activity patterns depicted in a web-based symptom diary could help predict clinical outcomes in patients with newly diagnosed CD. Patients diagnosed with CD within 3 months were prospectively enrolled from four tertiary centres. They recorded their symptoms on a website using a smartphone at least once a week. The index outcomes were disease-related admissions and surgery during follow-up. The disease activity from enrolment to outcome or last follow-up was reviewed for pattern analysis. Cox regression was used to identify the predictors of disease outcomes. Among 135 patients with new CD, 102 were enrolled in the study. During a median follow-up period of 42 months, 25 (24.5%) and 6 (5.9%) patients required admission and surgery, respectively. Poor activity pattern was an independent predictor of disease-related hospitalisation (adjusted hazard ratio [aHR], 3.96; 95% confidence interval [CI], 1.5–10.45; p=0.005). A poor activity pattern (aHR, 19.48; 95% CI, 1.86–203.95; p=0.013) and female (aHR, 11.28; 95% CI, 1.49–85.01; p=0.018) were found to be independent predictors of bowel resection. CD disease activity patterns monitored through the mobile monitoring system could predict clinical outcomes, such as disease-related hospitalisation and surgery, in patients with newly diagnosed CD.
- 18 August 2023
- Published by Springer Nature in Research Square
Open AccessMobile monitoring system to detect the disease activity pattern and predict clinical outcomes in patients with newly diagnosed Crohn’s disease
We aimed to determine whether Crohn’s disease (CD) activity patterns depicted in a web-based symptom diary could help predict clinical outcomes in patients with newly diagnosed CD. Patients diagnosed with CD within 3 months were prospectively enrolled from four tertiary centres. They recorded their symptoms on a website using a smartphone at least once a week. The index outcomes were disease-related admissions and surgery during follow-up. The disease activity from enrolment to outcome or last follow-up was reviewed for pattern analysis. Cox regression was used to identify the predictors of disease outcomes. Among 135 patients with new CD, 102 were enrolled in the study. During a median follow-up period of 42 months, 25 (24.5%) and 6 (5.9%) patients required admission and surgery, respectively. Poor activity pattern was an independent predictor of disease-related hospitalisation (adjusted hazard ratio [aHR], 3.96; 95% confidence interval [CI], 1.5–10.45; p=0.005). A poor activity pattern (aHR, 19.48; 95% CI, 1.86–203.95; p=0.013) and female (aHR, 11.28; 95% CI, 1.49–85.01; p=0.018) were found to be independent predictors of bowel resection. CD disease activity patterns monitored through the mobile monitoring system could predict clinical outcomes, such as disease-related hospitalisation and surgery, in patients with newly diagnosed CD.
- 21 June 2017
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 62 (9) , 2489-2497
Comparison of 4-L Polyethylene Glycol and 2-L Polyethylene Glycol Plus Ascorbic Acid in Patients with Inactive Ulcerative Colitis
Background Although colonoscopy preparation may cause symptom flares in patients with ulcerative colitis (UC), little is known about the standard preparation regimen in this population. Aim We aimed to compare 4L polyethylene glycol (4L-PEG) with 2L polyethylene glycol plus ascorbic acid (2L-PEG-Asc) in quiescent UC patients. Methods Patients with inactive UC undergoing colonoscopy for surveillance or checkup of mucosal healing were prospectively enrolled at 5 tertiary hospitals. They were randomly assigned to 4L-PEG and 2L-PEG-Asc groups. The Boston Bowel Preparation Scale (BBPS) was used for the preparation quality. Symptoms were assessed using the Simple Clinical Colitis Activity Index (SCCAI) before colonoscopy, at 1 and 4 weeks after the procedure. Results Overall, 109 patients were included in the study (4L-PEG group 53, 2L-PEG-Asc group 56, the mean age at diagnosis 42.25 years, male 77). The quality of preparation was comparable between the groups (BBPS ≥ 6, 96.2 vs. 92.9%, p = 0.679). Although 26 patients (23.8%) had increased SCCAI scores within 4 weeks after colonoscopy, resulting in a medication dose-up or add-on in 3 patients (2.7%), the rise in scores was not different between the groups. No serious adverse events during preparation were observed in either group. However, the 2L-PEG-Asc group was more likely to be willing to repeat the preparation with the same agent than the 4L-PEG group (82.1 vs. 64.2%, respectively, p = 0.034). Conclusion PEG-based regimens with different volumes are equally effective and safe in inactive UC patients. 2L-PEG-Asc is more acceptable in this population as indicated by the willingness for further usage.
- 21 June 2017
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 62 (9) , 2489-2497
Comparison of 4-L Polyethylene Glycol and 2-L Polyethylene Glycol Plus Ascorbic Acid in Patients with Inactive Ulcerative Colitis
Background Although colonoscopy preparation may cause symptom flares in patients with ulcerative colitis (UC), little is known about the standard preparation regimen in this population. Aim We aimed to compare 4L polyethylene glycol (4L-PEG) with 2L polyethylene glycol plus ascorbic acid (2L-PEG-Asc) in quiescent UC patients. Methods Patients with inactive UC undergoing colonoscopy for surveillance or checkup of mucosal healing were prospectively enrolled at 5 tertiary hospitals. They were randomly assigned to 4L-PEG and 2L-PEG-Asc groups. The Boston Bowel Preparation Scale (BBPS) was used for the preparation quality. Symptoms were assessed using the Simple Clinical Colitis Activity Index (SCCAI) before colonoscopy, at 1 and 4 weeks after the procedure. Results Overall, 109 patients were included in the study (4L-PEG group 53, 2L-PEG-Asc group 56, the mean age at diagnosis 42.25 years, male 77). The quality of preparation was comparable between the groups (BBPS ≥ 6, 96.2 vs. 92.9%, p = 0.679). Although 26 patients (23.8%) had increased SCCAI scores within 4 weeks after colonoscopy, resulting in a medication dose-up or add-on in 3 patients (2.7%), the rise in scores was not different between the groups. No serious adverse events during preparation were observed in either group. However, the 2L-PEG-Asc group was more likely to be willing to repeat the preparation with the same agent than the 4L-PEG group (82.1 vs. 64.2%, respectively, p = 0.034). Conclusion PEG-based regimens with different volumes are equally effective and safe in inactive UC patients. 2L-PEG-Asc is more acceptable in this population as indicated by the willingness for further usage.